Vir Biotechnology, Inc. (VIR)
9.16
-0.32
(-3.38%)
USD |
NASDAQ |
Mar 18, 15:20
Vir Biotechnology Profit Margin (Quarterly) : -66.99% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 3.33% |
| BioMarin Pharmaceutical, Inc. | -5.20% |
| Xeris Biopharma Holdings, Inc. | 12.91% |
| Gossamer Bio, Inc. | -362.7% |
| Sensei Biotherapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -46.56% |
| Return on Assets | -36.69% |
| Return on Invested Capital | -42.14% |
| Gross Profit Margin (Quarterly) | 95.44% |
| Operating Margin (Quarterly) | -74.92% |
| Return on Net Operating Assets | -298.8% |